technetium has been researched along with lactic acid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaba, DM; Maxwell, MS; Merlone, S; Smith, C | 1 |
| Ciftci, K; Ercan, TM; Guven, O; Hincal, AA; Kas, HS; Ruacan, S; Sungur, A | 1 |
| Delgado, A; Evora, C; Oliva, M; Sánchez, E; Soriano, I | 1 |
| Dullens, HF; Hennink, W; Kicken, M; Koole, R; Nijsen, JF; Slootweg, PJ; van der Bilt, A; van Es, RJ | 1 |
| Brown, CF; Fredrickson, JK; Gorby, YA; Liu, C; Zachara, JM | 1 |
| Fanning, KJ; Roberts, MS | 1 |
| Huang, KH; Li, XX; Liu, JH; Lu, XP; Zhou, SY; Zhu, ZH | 1 |
| Bera, H; Debnath, MC; Ghosh, LK; Gupta, BK; Halder, KK; Mandal, B | 1 |
| Babbar, AK; Saha, RN; Sharma, RK; Snehalatha, M; Venugopal, K | 1 |
| Debnath, MC; Ganguly, S; Ghosal, SK; Halder, KK; Kamila, MM; Mondal, N; Pal, TK; Sarkar, BR | 1 |
| Dandekar, P; Hassan, PA; Jain, R; Pandey, U; Patravale, V; Samuel, G; Subramanian, S; Venkatesh, M | 1 |
| Dixit, VK; Giri, N; Karwasara, VS; Pandey, RS; Tomar, P | 1 |
| Calis, S; Dimchevska, S; Geskovski, N; Goracinova, K; Kuzmanovska, S; Petrusevska, M; Simonoska Crcarevska, M; Zdravkovski, P | 1 |
| Albernaz, Mde S; de Carvalho, SM; Patricio, BF; Santos-Oliveira, R; Sarcinelli, MA; Weissmüller, G | 1 |
| Adan, J; Baldi, G; Comes Franchini, M; Fragogeorgi, EA; Innocenti, C; Locatelli, E; Loudos, G; Masa, M; Mazzantini, F; Psimadas, D; Ravagli, C; Sangregorio, C | 1 |
| Baishya, R; Debnath, MC; Ganguly, S; Gupta, A; Kumar, D; Nayak, DK; Sinha, S | 1 |
16 other study(ies) available for technetium and lactic acid
| Article | Year |
|---|---|
Internal countershock produces myocardial damage and lactate production without myocardial ischemia in anesthetized dogs.
Topics: Animals; Coronary Circulation; Diphosphates; Dogs; Electric Countershock; Hemodynamics; Lactates; Lactic Acid; Microspheres; Myocardium; Necrosis; Regional Blood Flow; Technetium; Technetium Tc 99m Pyrophosphate | 1987 |
Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
Topics: Animals; Antimetabolites, Antineoplastic; Biodegradation, Environmental; Chemistry, Pharmaceutical; Drug Delivery Systems; Female; Fluorouracil; Humans; Lactic Acid; Liver Neoplasms, Experimental; Microspheres; Molecular Weight; Particle Size; Polyesters; Polymers; Rats; Rats, Wistar; Technetium; Tissue Distribution; Viscosity | 1997 |
Radiolabelled biodegradable microspheres for lung imaging.
Topics: Animals; Lactic Acid; Lung; Microspheres; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Radionuclide Imaging; Rats; Rats, Wistar; Surface-Active Agents; Technetium; Tissue Distribution | 2000 |
Tumour embolization of the Vx2 rabbit head and neck cancer model with Dextran hydrogel and Holmium-poly(L-lactic acid) microspheres: a radionuclide and histological pilot study.
Topics: Analysis of Variance; Animals; Brachytherapy; Dextrans; Embolization, Therapeutic; Extravasation of Diagnostic and Therapeutic Materials; Female; Head and Neck Neoplasms; Holmium; Lactic Acid; Microspheres; Neoplasms, Experimental; Particle Size; Pilot Projects; Polyesters; Polymers; Rabbits; Radioisotopes; Radionuclide Imaging; Technetium | 2001 |
Reduction kinetics of Fe(III), Co(III), U(VI), Cr(VI), and Tc(VII) in cultures of dissimilatory metal-reducing bacteria.
Topics: Biodegradation, Environmental; Cells, Cultured; Chromium; Cobalt; Computer Simulation; Deltaproteobacteria; Hydrogen; Iron; Kinetics; Lactic Acid; Metals; Models, Biological; Oxidation-Reduction; Shewanella; Shewanella putrefaciens; Species Specificity; Technetium; Uranium | 2002 |
Characterization of the physiological spaces and distribution of tolbutamide in the perfused rat pancreas.
Topics: Algorithms; Animals; Carbon Radioisotopes; Duodenum; Erythrocytes; Extracellular Space; Glucose; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin; Insulin Secretion; Lactic Acid; Male; Oxygen Consumption; Pancreas; Perfusion; Rats; Rats, Wistar; Technetium; Tissue Distribution; Tolbutamide; Tritium | 2007 |
[Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts].
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorouracil; Humans; Lactic Acid; Male; Mice; Mice, SCID; Nanoparticles; Polyesters; Polymers; Radioimmunotherapy; Stomach Neoplasms; Technetium; Vascular Endothelial Growth Factor A | 2007 |
Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies.
Topics: Animals; Anti-Bacterial Agents; Chelating Agents; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chloramphenicol; Drug Stability; Electrochemistry; Hydrogen-Ion Concentration; Injections, Intravenous; Isotope Labeling; Lactic Acid; Mice; Microscopy, Electron, Transmission; Nanoparticles; Pentetic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Technetium; Tin Compounds; Tissue Distribution | 2008 |
Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Drug Compounding; Drug Delivery Systems; Drug Stability; Etoposide; Injections, Intravenous; Isotope Labeling; Lactic Acid; Male; Mice; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2008 |
Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice.
Topics: Animals; Aromatase Inhibitors; Carcinoma, Ehrlich Tumor; Drug Carriers; Drug Delivery Systems; Drug Stability; Freeze Drying; Lactic Acid; Letrozole; Mice; Nanoparticles; Nitriles; Particle Size; Pentetic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Technetium; Tissue Distribution; Triazoles | 2010 |
Technetium-99m-labeled poly(DL-lactide-co-glycolide) nanoparticles as an alternative for sentinel lymph node imaging.
Topics: Animal Structures; Animals; Cryoprotective Agents; Female; Freeze Drying; Isotope Labeling; Lactic Acid; Lymph Nodes; Microscopy, Atomic Force; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radionuclide Imaging; Rats; Rats, Wistar; Sentinel Lymph Node Biopsy; Surface-Active Agents; Technetium; Tissue Distribution; Vitamin E | 2010 |
Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B.
Topics: Animals; Drug Delivery Systems; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Interferon-alpha; Lactic Acid; Liver; Mice; Mice, Inbred BALB C; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radionuclide Imaging; Technetium; Tissue Distribution | 2011 |
Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure.
Topics: Animals; Borohydrides; Colloids; Dithionite; Female; Isotope Labeling; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiopharmaceuticals; Rats; Rats, Wistar; Reducing Agents; Surface-Active Agents; Technetium; Tin Compounds; Tissue Distribution | 2013 |
Development of novel nanoparticle for bone cancer.
Topics: Animals; Bone Neoplasms; Injections; Lactic Acid; Nanoparticles; Organophosphorus Compounds; Polyesters; Polymers; Polyvinyl Alcohol; Radionuclide Imaging; Rats; Rats, Wistar; Staining and Labeling; Technetium; Tissue Distribution | 2014 |
In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; ErbB Receptors; Female; Humans; Hyperthermia, Induced; Lactic Acid; Magnetite Nanoparticles; Mice; Mice, SCID; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Emulsions; Lactic Acid; Melanoma, Experimental; Mice; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiopharmaceuticals; Rats, Sprague-Dawley; Surface Properties; Technetium; Tissue Distribution; Triterpenes; Ursolic Acid | 2016 |